BR0210293A - Uma preparação farmacêutica aquosa de cilostazol para utilização parenteral - Google Patents
Uma preparação farmacêutica aquosa de cilostazol para utilização parenteralInfo
- Publication number
- BR0210293A BR0210293A BR0210293-5A BR0210293A BR0210293A BR 0210293 A BR0210293 A BR 0210293A BR 0210293 A BR0210293 A BR 0210293A BR 0210293 A BR0210293 A BR 0210293A
- Authority
- BR
- Brazil
- Prior art keywords
- cilostazol
- pharmaceutical preparation
- aqueous pharmaceutical
- parenteral use
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"UMA PREPARAçãO FARMACêUTICA AQUOSA DE CILOSTAZOL PARA UTILIZAçãO PARENTERAL". A presente invenção se refere a uma preparação farmacêutica aquosa de cilostazol para utilização parenteral. Em concordância com a presente invenção, a adição de um composto de ciclodextrina para a preparação farmacêutica aquosa de cilostazol para utilização parenteral que compreende cilostazol ou um sal farmacologicamente aceitável do mesmo como um ingrediente ativo, pode aumentar a solubilidade em água de cilostazol ou um sal farmacologicamente aceitável do mesmo, dando uma preparação farmacêutica aquosa para utilização parenteral de cilostazol ou um sal farmacologicamente aceitável do mesmo, da qual a estabilidade com o tempo no estado líquido é aperfeiçoada.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001179239 | 2001-06-13 | ||
JP2002127065A JP2003063965A (ja) | 2001-06-13 | 2002-04-26 | 注射用シロスタゾール水性製剤 |
PCT/JP2002/005705 WO2002102383A1 (fr) | 2001-06-13 | 2002-06-07 | Preparation de cilostazol aqueuse pour injections |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0210293A true BR0210293A (pt) | 2004-07-13 |
Family
ID=26616861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0210293-5A BR0210293A (pt) | 2001-06-13 | 2002-06-07 | Uma preparação farmacêutica aquosa de cilostazol para utilização parenteral |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040209843A1 (pt) |
EP (1) | EP1396266A1 (pt) |
JP (1) | JP2003063965A (pt) |
KR (1) | KR100720886B1 (pt) |
CN (1) | CN1223347C (pt) |
AR (1) | AR034370A1 (pt) |
AU (1) | AU2002306329B2 (pt) |
BR (1) | BR0210293A (pt) |
CA (1) | CA2443466A1 (pt) |
HK (1) | HK1064056A1 (pt) |
MX (1) | MXPA03011480A (pt) |
WO (1) | WO2002102383A1 (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4836797B2 (ja) * | 2003-10-23 | 2011-12-14 | 大塚製薬株式会社 | 放出制御性無菌注射アリピプラゾール製剤および方法 |
TWI338583B (en) | 2004-05-20 | 2011-03-11 | Otsuka Pharma Co Ltd | Solid pharmaceutical formulation |
US8506934B2 (en) | 2005-04-29 | 2013-08-13 | Robert I. Henkin | Methods for detection of biological substances |
KR100667367B1 (ko) * | 2005-05-10 | 2007-01-10 | 충남대학교산학협력단 | 용해도가 개선된 실로스타졸 복합체 조성물 및 그 제조방법 |
US20090042849A1 (en) * | 2006-12-06 | 2009-02-12 | Yochai Birnbaum | Phosphorylation of 5-lipoxygenase at ser523 and uses thereof |
WO2008095136A2 (en) | 2007-01-31 | 2008-08-07 | Henkin Robert I | Methods for detection of biological substances |
AR067747A1 (es) | 2007-07-31 | 2009-10-21 | Otsuka Pharma Co Ltd | Metodos para producir suspension de aripiprazol y formulacion liofilizada |
AR067746A1 (es) * | 2007-08-02 | 2009-10-21 | Otsuka Pharma Co Ltd | Un medicamento para tratar glaucoma que comprende como elemento activo compuesto de ciclodextrina - clatrato de cilostazol |
US8580801B2 (en) * | 2008-07-23 | 2013-11-12 | Robert I. Henkin | Phosphodiesterase inhibitor treatment |
US20110092456A1 (en) * | 2009-10-19 | 2011-04-21 | Yochai Birnbaum | Methods of increasing cAMP levels and uses thereof |
WO2013043985A1 (en) | 2011-09-23 | 2013-03-28 | The Regents Of The University Of California | Edible oils to enhance delivery of orally administered steroids |
CN104736158A (zh) * | 2012-01-23 | 2015-06-24 | 萨奇治疗股份有限公司 | 神经活性类固醇制剂和治疗中枢神经系统障碍的方法 |
RU2667010C2 (ru) | 2012-08-21 | 2018-09-13 | Сейдж Терапьютикс, Инк. | Способы лечения эпилепсии или эпилептического статуса |
EP4335505A3 (en) | 2012-11-30 | 2024-06-05 | The Regents of The University of California | Anticonvulsant activity of steroids |
CA2903300A1 (en) * | 2013-03-15 | 2014-09-25 | Epizyme, Inc. | Injectable formulations for treating cancer |
WO2015126944A1 (en) | 2014-02-18 | 2015-08-27 | Henkin Robert I | Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell |
KR101648740B1 (ko) * | 2014-09-04 | 2016-08-17 | 경상대학교산학협력단 | 실로스타졸을 유효성분으로 포함하는 독소루비신에 의한 심부전 또는 확장성 심근병증의 예방용 약학 조성물 |
JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
EP3370693B1 (en) * | 2015-11-06 | 2020-01-08 | Carinopharm GmbH | Improved formulations of levosimendan for intravenous administration as infusion or injection and of infusion concentrate |
JP6838074B2 (ja) | 2016-03-08 | 2021-03-03 | セージ セラピューティクス, インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
WO2021099973A1 (en) * | 2019-11-22 | 2021-05-27 | Shilpa Medicare Limited | Injectable compositions of ursodeoxycholic acid |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5535019A (en) * | 1978-09-01 | 1980-03-11 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
JPS5649378A (en) * | 1979-08-25 | 1981-05-02 | Otsuka Pharmaceut Co Ltd | Tetrazolylalkoxycarbostyril derivative |
IT1263831B (it) * | 1993-01-29 | 1996-09-04 | Paolo Chiesi | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina |
WO1999062958A1 (en) * | 1998-05-29 | 1999-12-09 | Janssen Pharmaceutica N.V. | Acylated alkylated cyclodextrin derivatives and their use as carriers for medicaments |
GEP20043214B (en) * | 1999-01-21 | 2004-04-26 | Bristol Myers Squibb Company Us | Complex of Ras-Farnesyltransferase Inhibitor and Sulfobutylether-7- Beta – Cyclodextrin or 2-Hydroxypropyl- Beta – Cyclodextrina and Pharmaceutical Compositions Containing the Same |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
-
2002
- 2002-04-26 JP JP2002127065A patent/JP2003063965A/ja active Pending
- 2002-06-06 AR ARP020102104A patent/AR034370A1/es not_active Application Discontinuation
- 2002-06-07 AU AU2002306329A patent/AU2002306329B2/en not_active Ceased
- 2002-06-07 BR BR0210293-5A patent/BR0210293A/pt not_active IP Right Cessation
- 2002-06-07 US US10/480,289 patent/US20040209843A1/en not_active Abandoned
- 2002-06-07 WO PCT/JP2002/005705 patent/WO2002102383A1/ja not_active Application Discontinuation
- 2002-06-07 MX MXPA03011480A patent/MXPA03011480A/es active IP Right Grant
- 2002-06-07 KR KR1020037015549A patent/KR100720886B1/ko not_active IP Right Cessation
- 2002-06-07 CN CNB028091868A patent/CN1223347C/zh not_active Expired - Fee Related
- 2002-06-07 CA CA002443466A patent/CA2443466A1/en not_active Abandoned
- 2002-06-07 EP EP02733420A patent/EP1396266A1/en not_active Withdrawn
-
2004
- 2004-09-13 HK HK04106926A patent/HK1064056A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA03011480A (es) | 2004-03-18 |
CN1505513A (zh) | 2004-06-16 |
AU2002306329B2 (en) | 2006-11-30 |
WO2002102383A1 (fr) | 2002-12-27 |
CN1223347C (zh) | 2005-10-19 |
US20040209843A1 (en) | 2004-10-21 |
CA2443466A1 (en) | 2002-12-27 |
HK1064056A1 (en) | 2005-01-21 |
EP1396266A1 (en) | 2004-03-10 |
AR034370A1 (es) | 2004-02-18 |
KR100720886B1 (ko) | 2007-05-22 |
JP2003063965A (ja) | 2003-03-05 |
KR20040005995A (ko) | 2004-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0210293A (pt) | Uma preparação farmacêutica aquosa de cilostazol para utilização parenteral | |
ES2244831T5 (es) | Uso de pantenol y/o ácido pantoténico y ácido hialurónico y/o hialuronato para la producción de una composición farmacéutica para aplicación oftalmológica | |
BR0317600A (pt) | ácidos heteroarilalcanóicos como derivados de antagonistas de receptor de integrina | |
EA200900152A1 (ru) | Ингибиторы пирролотриазинкиназы | |
WO2004067550A3 (fr) | Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications | |
BR0109703A (pt) | Derivados de piperazina | |
FR2805817B1 (fr) | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation | |
ES2196527T3 (es) | Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo. | |
RS50140B (sr) | Postupak za dobijanje perkihinina i njegova upotreba | |
IS8502A (is) | Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar | |
BRPI0518231A2 (pt) | derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica | |
WO2008026048A3 (en) | Stable injectable pharmaceutical compositions of docetaxel | |
BRPI0413186A (pt) | composição de fexofenadina e processo para preparação da mesma | |
NO20032261L (no) | Medisinske preparater | |
FR2942797B1 (fr) | Derives de benzothiazines, leur preparation et leur application a titre de medicaments | |
BR0113590A (pt) | 7-oxo-piridopirimidinas | |
IS8096A (is) | Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpum | |
EP1314719A4 (en) | BENZOIC ACID DERIVATIVES AND MEDICAMENTS HAVING THE SAME AS ACTIVE INGREDIENT | |
NO20025035D0 (no) | Oksadiazolderivater som har anticancer-effekter | |
EA200300406A1 (ru) | Фармацевтическая композиция дронедарона для парентерального введения | |
BR0104358A (pt) | Formulações de taxana tendo solubilidade aperfeiçoada | |
BR0309283A (pt) | Preparação lìquida compreendendo derivado de camptotecina e composição farmacêutica produzìvel por liofilização da preparação | |
WO2002026732A1 (fr) | Derive de benzodiazepine | |
DK1204658T3 (da) | Benzofurylpiperazin-serotoninagonister | |
NO20031410L (no) | Anvendelse av distamycinderivater for fremstilling av medikamenter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE 7A., E 8A. ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010. |